Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients
Titel:
Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients
Auteur:
Harbeck, N. Schmitt, M. Meisner, C. Friedel, C. Untch, M. Schmidt, M. Sweep, C.G.J. Lisboa, B.W. Lux, M.P. Beck, T. Hasmüller, S. Kiechle, M. Jänicke, F. Thomssen, C.